Orion Biotech Opportunities (Orion Biotech Opportunities) Accounts Receivable : $0.00 Mil (As of Dec. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Orion Biotech Opportunities Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Orion Biotech Opportunities's accounts receivables for the quarter that ended in Dec. 2022 was $0.00 Mil.

Accounts receivable can be measured by Days Sales Outstanding.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Orion Biotech Opportunities's Net-Net Working Capital per share for the quarter that ended in Dec. 2022 was $N/A.

Orion Biotech Opportunities Accounts Receivable Historical Data

The historical data trend for Orion Biotech Opportunities's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Biotech Opportunities Accounts Receivable Chart

Orion Biotech Opportunities Annual Data

Trend

Dec21

Dec22

Accounts Receivable

Orion Biotech Opportunities Quarterly Data
	Feb21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Accounts Receivable	Get a 7-Day Free Trial			-	-	-	-	-

Orion Biotech Opportunities Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Orion Biotech Opportunities Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Orion Biotech Opportunities's Days Sales Outstanding for the quarter that ended in Dec. 2022 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	0	*	91
=

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Orion Biotech Opportunities's accounts receivable are only considered to be worth 75% of book value:

Orion Biotech Opportunities's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2022 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(0.266	+	0.75 * 0	+	0.5 * 0	-	8.332
-	0	-	0)	/	0
=	N/A

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Orion Biotech Opportunities Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Orion Biotech Opportunities's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.